Sir William Martin CastellLVOFMedSci (born 10 April 1947) is a British businessman who was chairman of the Wellcome Trust, a director of General Electric and a former director of BP. He was CEO of Amersham plc from 1989 until it was acquired by GE in April 2004 and then became CEO of GE Healthcare and a vice-chairman of GE.
Castell was educated at St. Dunstan's College and Cass Business School, where he earned a BA. He qualified as an accountant with Spicer and Pegler (1971–75) and then joined Wellcome plc as financial controller of Europe (1976–79), rising to MD Wellcome Biotech (1982–84) and commercial director (1984–89).
He was a non-executive director of The General Electric Company (UK) which became Marconi plc 1997–2002, and was appointed a non-executive director of BP in 2006, until April 2012.
He joined the board of governors of the Wellcome Trust as chairman-designate on 1 January 2006, succeeding Sir Dominic Cadbury as chairman in May 2006. Prior to joining Amersham, he held various positions with the Wellcome pharmaceutical company, which was then owned by the Wellcome Trust.
Sir Richard Lake Olver FREng was the chairman of BAE Systems, one of the world's largest defence contractors.
Jeffrey Robert Immelt is an American manufacturing executive working as a venture partner at New Enterprise Associates. He previously was the CEO of General Electric from 2001 to 2017, and the CEO of GE's Medical Systems division from 1997 to 2000. Immelt's tenure saw GE's largest divestments in the company's history, as the company sold almost two-thirds of its subsidiaries and assets.
GE HealthCare Technologies, Inc., organized in Delaware and headquartered in Chicago, Illinois, focuses on health technology. The company operates 4 divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures contrast agents and radiopharmaceuticals.
Sir Nicholas Dominic Cadbury is a British businessman and member of the Cadbury chocolate manufacturing dynasty. He was the sixth chancellor of University of Birmingham, stepping down in 2014.
Edmund John Phillip Browne, Baron Browne of Madingley, is a British businessman.
Bayes Business School, formerly known as Cass Business School, is the business school of the City, University of London, located in St Luke's, just to the north of the City of London. It was established in 1966.
Sir Roy Alan Gardner is a British businessman. He is a former director of English football clubs Manchester United and Plymouth Argyle. While at Manchester United, he was involved in the sale of the club to American businessman Malcolm Glazer before resigning in protest at the sale. His time as chairman of Plymouth Argyle resulted in the club entering administration with debts of over £17 million and accusations of financial mismanagement.
Iain Cameron Conn is a British businessman. He was the chief executive (CEO) of Centrica from 2015 to 2019.
Sir Thomas Fulton Wilson McKillop, FRS, FRSE, FMedSci is a Scottish chemist, who was CEO of AstraZeneca PLC from 1999 until 2006 and chairman of the RBS Group from 2006 until 2008.
Sir John Alexander Raymond Chisholm is a British engineer who was chairman of the Medical Research Council and QinetiQ.
Sir Robert Baynes Horton was a British businessman. He was a director of the European Advisory Council and of Emerson Electric Company. He spent 30 years working for BP, formerly British Petroleum. He became Chief Executive and Chairman of the Board of BP in March 1990, but was forced out in 1992.
Dame Patricia Anne Hodgson is a British broadcasting executive, competition regulator, and academic administrator.
Sir John Oliver Frank Kingman KCB FRS Hon FMedSci has been Chair of Legal & General PLC since 2016. He is also Chair of Barclays UK, the ring-fenced retail bank of Barclays PLC, and a member of the Barclays PLC board.
Sir John Irving Bell is a Canadian-British immunologist and geneticist. From 2006 to 2011, he was President of the United Kingdom's Academy of Medical Sciences, and since 2002 he has held the Regius Chair of Medicine at the University of Oxford. He was since 2006 Chairman of the Office for Strategic Coordination of Health Research (OSCHR) but in 2020 became a normal member. Bell was selected to the Vaccine Taskforce sometime before 1 July 2020. Bell is also on the board of directors of the SOE quango Genomics England.
Sir Thomas John Parker is a British businessman. He is chairman of Laing O'Rourke and former chairman of Pennon Group, a director of Carnival Corporation & plc and lead non-executive director at the Cabinet Office. He has been a director or chairman of numerous other public companies including Airbus, Anglo American plc, Babcock International, British Gas, DP World, Lattice Group, National Grid plc and Ombu Group. He is a past president of the Royal Academy of Engineering, patron at the Centre for Process Innovation and a Visiting Fellow of the University of Oxford.
Sir Robin Buchanan Nicholson was a British industrial metallurgist and academic, who served as Chief Scientific Adviser, Cabinet Office, from 1983 to 1985. He then joined the board of Rolls-Royce plc, where he served until 2005. He was also a non-executive board member of BP plc and Pilkington plc.
Andrew G. Inglis is a British engineer, corporate executive and CEO of Kosmos Energy.
Andrew Stephen Bower Knight is an English journalist, editor, and director of News Corporation.
Sir Tony Kouzarides, FMedSci, FRS is a senior group leader at the Gurdon Institute, a founding non-executive director of Abcam and a Professor of Cancer Biology at the University of Cambridge.
Trevor Mervyn Jones is a visiting professor at King's College London, and a former Head of R&D, at Wellcome. He was main board director for Research & Development at The Wellcome Foundation Ltd. During his tenure, the organisation was responsible for the development of a number of significant products.
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.
